Lymphoma Expert Suggests Asking About Clinical Trials Soon After Diagnosis

Treating patients with CAR-T cell therapy Breyanzi may change the paradigm for those with relapsed or refractory mantle cell lymphoma, an expert said.

CURE® editors discuss last week’s biggest cancer headlines, from Dexter Scott King’s death to the potential of laughter therapy to boost quality of life.

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.

From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.

After fully recovering from non-Hodgkin lymphoma, I’m ready to embark on my next chapter in life doing the things I love with the people I love.

I was told that after five years in remission, my cancer would be behind me. However, I was not told what life would be like after that milestone.